OXYTOCIN AND CARBOPROST IN DELIVERY
Phase 2
- Conditions
- Health Condition 1: O80- Encounter for full-term uncomplicated delivery
- Registration Number
- CTRI/2019/05/018908
- Lead Sponsor
- Dr Shanthi Subramani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women with singleton pregnancy with cephalic presentation beyond 37 completed weeks of gestation in labour for vaginal Delivery.
Exclusion Criteria
1. Traumatic PPH
2. Hypertensive disorders of pregnancy. 3. Anaemia (Hb <8 g/dl)
4. Multiple pregnancies
5. Polyhydramnios
6. Grand multipara
7. Bronchial Asthma
8. Macrosomia( > 4 kg).
9. Hypersensitivity to drugs.
10. Intrauterine fetal death.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess and compare the effectiveness of intramuscular oxytocin with intramuscular carboprost in the active management of third stage of labourTimepoint: From delivery of baby to before delivery of placenta.
- Secondary Outcome Measures
Name Time Method To assess amount of blood loss during third stage of labour. <br/ ><br>Duration of third stage of labour Will be measured and additional oxytocics requirement and side effects of drug will be measured.Timepoint: Third stage of labour.